Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Researchers find clues about how antibodies specialize

24.08.2004


Gene mutations are closely targeted -- enhancing the immune response while avoiding cancer

Researchers at Children’s Hospital Boston have begun unraveling the mystery of how B lymphocytes -- key infection-fighting cells in the body -- are able to create many different kinds of specialized antibodies through selective gene mutations, while being protected from random mutations that could give rise to cancers.

The findings, reported in the Aug. 26 issue of the journal Nature, will help scientists better understand two things: how the body is able to mount a strong immune defense against foreign attackers, and how cancers, particularly lymphomas, develop and might be prevented.



B lymphocytes, or B cells, are the immune-system cells responsible for producing antibodies – proteins that recognize, bind to, and neutralize viruses and other harmful pathogens. Since there is a huge diversity of pathogens in the environment – more than our genomes could possibly anticipate and encode for -- the antibody response has to be very fluid and adaptable. The human immune system handles antibody diversification through selective mutations to specific stretches of DNA in B cells that encode immunoglobulins, the proteins from which antibodies are made. Mutations in these gene segments – to the so-called variable regions -- give our B cells the ability to make unique, specialized antibodies with high affinity for a specific invader.

This mutation process, known as somatic hypermutation, is known to require an enzyme called activation-induced cytidine deaminase (AID). But how AID targets the variable region of the immunoglobulin genes -- while leaving the rest of the genetic material in the B cell untouched -- has been a mystery.

In the biochemical study reported in Nature, the Children’s Hospital Boston researchers discovered that another protein, known as replication protein A (RPA), interacts with AID, attaches to it, and directs AID to the specific segment of the B cell’s DNA required for a tailored immune response. The study details the process by which AID is biochemically modified to promote its interaction with RPA.

"Such a targeting mechanism for AID is essential for our immune system," says Dr. Frederick W. Alt, a Howard Hughes Medical Institute researcher at the Children’s Department of Molecular Medicine and senior investigator on the study. "Without it, we’d be immunodeficient, unable to diversify our antibody repertoire."

The Children’s study also has implications for the prevention of lymphomas, notes Dr. Jayanta Chaudhuri, first author on the study and a postdoctoral fellow in Alt’s laboratory.

"The AID-RPA interaction must be regulated to bring about the specificity of the mutation," Chaudhuri says. "If this regulation is impaired for some reason, then the B cell would incur a lot of random mutations and that might lead to tumors."

The next step, then, is to figure out what sometimes goes wrong and allows the AID-RPA complex to go to the wrong regions, potentially leading to activation of cancer genes. "Now that we’ve learned how AID gets access to the variable regions, we can ask how the process goes awry to cause mutations of genes that could lead to cancer," says Alt.

RPA is found throughout the body, and is known to be involved in repairing damaged DNA, but until now, it hadn’t been known to have a role in the immune system. "We’ve discovered a new function for it," says Alt. "It’s generating quite a bit of excitement in the immunology field and promises to teach us more about the immune response."

Alt has spent his career exploring the immune system’s ability to defend against a vast array of antigens through genetic rearrangements, as well as the mechanisms the body uses to suppress genomic instability, an increased tendency toward gene mutation that can lead to cancer. In recent years, these two lines of investigation--immunology and cancer -- have intersected and informed each other.

Aaron Patnode | EurekAlert!
Further information:
http://www.harvard.edu
http://www.childrenshospital.org

More articles from Life Sciences:

nachricht Rochester scientists discover gene controlling genetic recombination rates
23.04.2018 | University of Rochester

nachricht One step closer to reality
20.04.2018 | Max-Planck-Institut für Entwicklungsbiologie

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Spider silk key to new bone-fixing composite

University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.

Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

Im Focus: Gamma-ray flashes from plasma filaments

Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.

The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...

Im Focus: Basel researchers succeed in cultivating cartilage from stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...

Im Focus: Like a wedge in a hinge

Researchers lay groundwork to tailor drugs for new targets in cancer therapy

In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

IWOLIA: A conference bringing together German Industrie 4.0 and French Industrie du Futur

09.04.2018 | Event News

 
Latest News

Tiny microenvironments in the ocean hold clues to global nitrogen cycle

23.04.2018 | Earth Sciences

Joining metals without welding

23.04.2018 | Trade Fair News

Researchers illuminate the path to a new era of microelectronics

23.04.2018 | Information Technology

VideoLinks
Science & Research
Overview of more VideoLinks >>>